Delhi HC backs Zydus in trademark row

The Delhi High Court upheld a single-judge order against Alder Biochem. This ruling prevents them from using the 'Biochem' trademark. Alder Biochem's claim of the term being public property was rejected. Zydus Healthcare has held the registered trademark since 1959. The court's decision protects Zydus Healthcare's established brand.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gW8LpqF
via IFTTT

Read More

Narayana Health, NDB sign pact to share smart hospital expertise

Narayana Health and the New Development Bank have signed a knowledge-sharing agreement. This partnership aims to strengthen smart hospital capabilities and patient-centric healthcare services. The collaboration will focus on digital health and technology transfer for emerging economies. NDB president Dilma Rousseff and Narayana Health chairman Dr Devi Shetty signed the memorandum. This initiative supports NDB's mission to finance development projects in emerging markets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6KRl4BX
via IFTTT

Read More

Govt tightens drug quality net, initiates 950 actions since 2022: Over 1,100 cough syrup makers are also facing intensive audits amid quality concerns

The government has initiated 950 enforcement actions against pharmaceutical companies since December 2022. These actions aim to improve the quality of locally made medicines and prevent spurious drug sales. More than 1,100 cough syrup manufacturers are facing intense audits due to quality concerns. Drug manufacturing premises are inspected periodically to verify compliance with good manufacturing practices. Risk-based inspections are now prioritized based on a company's risk profile.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gSt4ryk
via IFTTT

Read More

Maharashtra FDA cracks down on Ayurvedic drug makers, cancels 10 licences

Maharashtra FDA has launched a statewide crackdown on Ayurvedic drug manufacturers. Inspections revealed serious violations of manufacturing and quality control standards at many establishments. Following these findings, 135 manufacturers received show-cause notices for non-compliance issues. Ten manufacturers had their licenses permanently cancelled due to major violations affecting public health. The FDA is ensuring Ayurvedic medicines meet required standards and addressing public health lapses.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DpL0RfQ
via IFTTT

Read More

Regulator mandates full review of globally unapproved drugs

India’s drug regulator has clarified that new drugs not approved anywhere globally must undergo the full domestic regulatory process, even if Indian patients participated in global clinical trials. CDSCO said such applications require comprehensive safety and efficacy evaluation under existing rules.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/t7GwBYO
via IFTTT

Read More

US-based Amgen to open science and innovation center at Genome Valley in Hyderabad

Amgen will open a new science and innovation center in Hyderabad's Genome Valley. This facility is expected to become operational by the year 2027. The center will integrate experimental science with data and technology. It will expand Amgen's global research and development capabilities significantly. This investment highlights Hyderabad's growing importance as a global research hub.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nrjhl6a
via IFTTT

Read More

Philips India sees India emerging as global R&D, AI hub; bets on healthcare infrastructure for growth

Philips India is focusing on growing healthcare infrastructure and artificial intelligence. The company's R&D footprint in India is significantly strengthening its global operations. Investments will continue to support Philips' positive growth story in the country. Philips sees opportunities in sleep and respiratory care as awareness increases. The company prioritizes value over price when facing competition from other firms.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sVzXPZ0
via IFTTT

Read More